{"transactions":[{"id":738807,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2026-06-15T23:00:06.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":4.65,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-028768","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226028768/ownership.xml","form_type":"4"}},{"id":774426,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:35:23.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":4137,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14018,"source":{"system":"sec-edgar","filing":"0002064832-26-000206","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000206483226000206/form4.xml","form_type":"4"}},{"id":1022176,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:13.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.  Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":4.8,"expiration_date":"2028-07-20","underlying":"Common Stock","underlying_shares":12248},"source":{"system":"sec-edgar","filing":"0001193125-25-233535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233535/ownership.xml","form_type":"4"}},{"id":1022175,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:13.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.  Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.37,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":6124},"source":{"system":"sec-edgar","filing":"0001193125-25-233535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233535/ownership.xml","form_type":"4"}},{"id":1022174,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:13.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.  Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":4.53,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001193125-25-233535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233535/ownership.xml","form_type":"4"}},{"id":1022173,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:13.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.  Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":4.11,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":19750},"source":{"system":"sec-edgar","filing":"0001193125-25-233535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233535/ownership.xml","form_type":"4"}},{"id":1022172,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:13.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025.  Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(Continued from footnote 1) without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.85,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-25-233535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233535/ownership.xml","form_type":"4"}},{"id":1121270,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T16:59:12.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 3, 2026, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":30000,"derivative":{"exercise_price":3.85,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-25-082460","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000095017025082460/ownership.xml","form_type":"4"}},{"id":1144246,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2025-05-19T20:31:08.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":59000,"derivative":{"exercise_price":1.48,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":59000},"source":{"system":"sec-edgar","filing":"0001641172-25-011472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000164117225011472/ownership.xml","form_type":"4"}},{"id":1144906,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:38:10.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":4543,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4543,"derivative":{"exercise_price":78.81,"exercise_date":"2026-05-14","expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":4543},"source":{"system":"sec-edgar","filing":"0001062993-25-009689","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325009689/form4.xml","form_type":"4"}},{"id":1144905,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:38:10.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":2537,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9881,"source":{"system":"sec-edgar","filing":"0001062993-25-009689","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325009689/form4.xml","form_type":"4"}},{"id":1301135,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2025-01-17T21:07:05.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":1.42,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-002761","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315225002761/ownership.xml","form_type":"4"}},{"id":1436452,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2024-08-12T20:50:40.000Z","date":"2024-08-08","kind":"grant","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":1.02,"exercise_date":"2024-08-08","expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001493152-24-031314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224031314/ownership.xml","form_type":"4"}},{"id":1480655,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T17:00:07.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":19750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 11, 2025, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":19750,"derivative":{"exercise_price":4.11,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":19750},"source":{"system":"sec-edgar","filing":"0000950170-24-073121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000095017024073121/ownership.xml","form_type":"4"}},{"id":1518821,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-13T21:11:20.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":4853,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4853,"derivative":{"exercise_price":75.9,"exercise_date":"2025-05-09","expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":4853},"source":{"system":"sec-edgar","filing":"0000950170-24-058832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024058832/ownership.xml","form_type":"4"}},{"id":1518820,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T21:11:20.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":2635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7344,"source":{"system":"sec-edgar","filing":"0000950170-24-058832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017024058832/ownership.xml","form_type":"4"}},{"id":1760503,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T21:03:39.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":6,"price":86.2242,"value":517.3452,"ownership":{"direct":false,"nature":"By spouse's IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made by an investment advisor in an IRA for the reporting person's spouse and were not identified to the reporting person\nor Issuer at the time such transactions occured."}],"balance_after":16,"source":{"system":"sec-edgar","filing":"0000950170-23-053341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017023053341/ownership.xml","form_type":"4"}},{"id":1760502,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T21:03:39.000Z","date":"2022-09-30","kind":"other","planned":false,"acquired":true,"shares":6,"price":69.7682,"value":418.6092,"ownership":{"direct":false,"nature":"By spouse's IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made by an investment advisor in an IRA for the reporting person's spouse and were not identified to the reporting person\nor Issuer at the time such transactions occured."}],"balance_after":22,"source":{"system":"sec-edgar","filing":"0000950170-23-053341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017023053341/ownership.xml","form_type":"4"}},{"id":1760501,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T21:03:39.000Z","date":"2022-09-29","kind":"other","planned":false,"acquired":true,"shares":6,"price":66.9796,"value":401.8776,"ownership":{"direct":false,"nature":"By spouse's IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made by an investment advisor in an IRA for the reporting person's spouse and were not identified to the reporting person\nor Issuer at the time such transactions occured."}],"balance_after":16,"source":{"system":"sec-edgar","filing":"0000950170-23-053341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017023053341/ownership.xml","form_type":"4"}},{"id":1760500,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T21:03:39.000Z","date":"2022-09-23","kind":"other","planned":false,"acquired":true,"shares":4,"price":75.16,"value":300.64,"ownership":{"direct":false,"nature":"By spouse's IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made by an investment advisor in an IRA for the reporting person's spouse and were not identified to the reporting person\nor Issuer at the time such transactions occured."}],"balance_after":10,"source":{"system":"sec-edgar","filing":"0000950170-23-053341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017023053341/ownership.xml","form_type":"4"}},{"id":1760499,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T21:03:39.000Z","date":"2022-09-19","kind":"other","planned":false,"acquired":true,"shares":5,"price":83.4841,"value":417.4205,"ownership":{"direct":false,"nature":"By spouse's IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made by an investment advisor in an IRA for the reporting person's spouse and were not identified to the reporting person\nor Issuer at the time such transactions occured."}],"balance_after":6,"source":{"system":"sec-edgar","filing":"0000950170-23-053341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017023053341/ownership.xml","form_type":"4"}},{"id":1760498,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T21:03:39.000Z","date":"2022-09-19","kind":"other","planned":false,"acquired":true,"shares":1,"price":83.7937,"value":83.7937,"ownership":{"direct":false,"nature":"By spouse's IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made by an investment advisor in an IRA for the reporting person's spouse and were not identified to the reporting person\nor Issuer at the time such transactions occured."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-23-053341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000095017023053341/ownership.xml","form_type":"4"}},{"id":1775685,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-09-21T13:24:36.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":6.82,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0000899243-23-019368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019368/doc4.xml","form_type":"4"}},{"id":1775684,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-21T13:24:36.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award covering shares of Company Common Stock that is subject to vesting conditions based solely on continued employment or service granted under an Issuer equity plan (each, a \"Company RSU\") and each performance stock unit award covering shares of Company Common Stock that are subject to performance-based vesting conditions granted under an Issuer equity plan (each, a \"Company PSU\") (the Company RSUs and the Company PSUs, collectively \"Company Equity Awards\") that was then outstanding was cancelled, and the holder of such cancelled Company Equity Award is entitled, in exchange therefor, to receive (without interest and less applicable tax withholdings) (i) an amount in cash equal to the product of (A) the total number of shares of Company Common Stock subject to (or deliverable under) such Company Equity Award immediately prior to the Effective Time multiplied by (B) the Cash Consideration,"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) and (ii) a CVR Payment for each share of Company Common Stock subject thereto (the \"Equity Award Consideration\"), provided, that any payment of the Equity Award Consideration in respect of an unvested Company Equity Award will remain subject to the same vesting conditions as were applicable to such Company Equity Award immediately prior to the Effective Time and shall only become payable to the holder of such cancelled Company Equity Award to the extent such vesting conditions are satisfied following the closing of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-019368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019368/doc4.xml","form_type":"4"}},{"id":1775683,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-21T13:24:36.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 6, 2023, by and among the Issuer, Resistance Acquisition, Inc. (\"Parent\"), and Resistance Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into Issuer with the Issuer being the surviving corporation (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock of the Issuer (\"Company Common Stock\") was cancelled and retired and automatically converted into the right to receive (x) $2.15, payable to the holder thereof in cash, without interest (the \"Cash Consideration\") but subject to reduction for any applicable withholding taxes payable in respect thereof and (y) one (1) contractual contingent value right  (a \"CVR Payment\") that represents the right to receive $0.85 upon satisfaction of certain conditions set forth in a Contingent Value Rights Agreement, dated September 21, 2023, by and between Parent and Equiniti Trust Company, LLC."}],"balance_after":26400,"source":{"system":"sec-edgar","filing":"0000899243-23-019368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019368/doc4.xml","form_type":"4"}},{"id":1807975,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2023-08-15T16:27:44.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":4.25,"exercise_date":"2023-08-10","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001493152-23-028916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315223028916/ownership.xml","form_type":"4"}},{"id":1862223,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T16:15:37.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 6, 2024, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":17300,"derivative":{"exercise_price":11.71,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":17300},"source":{"system":"sec-edgar","filing":"0000899243-23-014862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924323014862/doc4.xml","form_type":"4"}},{"id":1893120,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-15T22:41:16.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":3798,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3798,"derivative":{"exercise_price":99.38,"exercise_date":"2024-05-11","expiration_date":"2033-05-11","underlying":"Common Stock","underlying_shares":3798},"source":{"system":"sec-edgar","filing":"0000899243-23-012998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924323012998/doc4.xml","form_type":"4"}},{"id":1893119,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T22:41:16.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":2012,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4709,"source":{"system":"sec-edgar","filing":"0000899243-23-012998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924323012998/doc4.xml","form_type":"4"}},{"id":2024999,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:04:00.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 8, 2023, subject to the Reporting Person's continued service with the Issuer through the vesting date."}],"balance_after":59200,"source":{"system":"sec-edgar","filing":"0000904454-23-000099","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445423000099/edgar.xml","form_type":"4"}},{"id":2183107,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2022-08-17T19:33:11.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":37000,"derivative":{"exercise_price":10.28,"exercise_date":"2023-08-11","expiration_date":"2032-08-11","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0000719135-22-000069","document":"wf-form4_166076477650839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913522000069/wf-form4_166076477650839.xml","form_type":"4"}},{"id":2231463,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T16:30:29.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 14, 2023, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":16300,"derivative":{"exercise_price":4.53,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0000899243-22-022574","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924322022574/doc4.xml","form_type":"4"}},{"id":2273151,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-12T21:50:43.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":4068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."}],"balance_after":4068,"derivative":{"exercise_price":64.2,"exercise_date":"2023-05-06","expiration_date":"2032-05-06","underlying":"Common Stock","underlying_shares":4068},"source":{"system":"sec-edgar","filing":"0000899243-22-017804","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924322017804/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-10"}},{"id":2275866,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-10T20:35:44.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":3616,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3616,"derivative":{"exercise_price":64.2,"exercise_date":"2023-05-06","expiration_date":"2032-05-06","underlying":"Common Stock","underlying_shares":3616},"source":{"system":"sec-edgar","filing":"0000899243-22-017440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924322017440/doc4.xml","form_type":"4"}},{"id":2275865,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-10T20:35:44.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":2180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units cliff vest on May 6, 2023."}],"balance_after":2697,"source":{"system":"sec-edgar","filing":"0000899243-22-017440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924322017440/doc4.xml","form_type":"4"}},{"id":2347232,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-08T01:41:05.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":517,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":517,"source":{"system":"sec-edgar","filing":"0000899243-22-009818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000089924322009818/doc4.xml","form_type":"4"}},{"id":2385781,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-18T17:09:57.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 16, 2022, subject to the Reporting Person's continued service with the Issuer through the vesting date."}],"balance_after":39200,"source":{"system":"sec-edgar","filing":"0000904454-22-000161","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000161/edgar.xml","form_type":"4"}},{"id":2607786,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2021-08-11T19:34:55.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":9.42,"exercise_date":"2022-08-06","expiration_date":"2031-08-06","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000719135-21-000058","document":"wf-form4_162871048053719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913521000058/wf-form4_162871048053719.xml","form_type":"4"}},{"id":2648115,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T16:23:06.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest as to 1/36 of the shares on July 31, 2021, and on the last day of each successive month thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":12800,"derivative":{"exercise_price":6.82,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0000904454-21-000570","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000570/edgar.xml","form_type":"4"}},{"id":2648114,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T16:23:06.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":19200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, pursuant to the Paratek Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, effective January 1, 2021. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest as to 1/3 of the shares subject to the restricted stock units on June 30, 2022, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":19200,"source":{"system":"sec-edgar","filing":"0000904454-21-000570","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000570/edgar.xml","form_type":"4"}},{"id":2673952,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T16:50:34.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 8, 2022, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":16300,"derivative":{"exercise_price":5.7,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0000899243-21-022981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924321022981/doc4.xml","form_type":"4"}},{"id":2922265,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T16:10:36.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":136030,"price":0.68,"value":92500.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 1, 2021, the reporting person was issued under the issuer's 2017 Equity Incentive Plan 18,383 Restricted Stock Units vesting in three equal monthly installments beginning February 1, 2021, and 117,647 Restricted Stock Units vesting in 12 monthly installments beginning February 1, 2021. The Restricted Stock Units represent a total value of $92,500 in annual and quarterly compensation awarded under the issuer's non-executive director compensation plan."}],"balance_after":207861,"source":{"system":"sec-edgar","filing":"0001493152-21-000210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315221000210/ownership.xml","form_type":"4"}},{"id":2950449,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-10T16:15:12.000Z","date":"2020-12-10","kind":"exercise","acquired":false,"shares":2992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On December 10, 2018, the reporting person was granted 8,975 restricted stock units that vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On December 10, 2018, the reporting person was granted 8,975 restricted stock units that vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On December 10, 2018, the reporting person was granted 8,975 restricted stock units that vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."}],"balance_after":2991,"derivative":{"underlying":"Common Stock","underlying_shares":2992},"source":{"system":"sec-edgar","filing":"0001493152-20-023267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315220023267/ownership.xml","form_type":"4"}},{"id":2950448,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-10T16:15:12.000Z","date":"2020-12-10","kind":"exercise","acquired":true,"shares":2992,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On December 10, 2018, the reporting person was granted 8,975 restricted stock units that vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."}],"balance_after":71831,"source":{"system":"sec-edgar","filing":"0001493152-20-023267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315220023267/ownership.xml","form_type":"4"}},{"id":3013970,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T16:05:48.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":12135,"price":1.03,"value":12499.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 1, 2020, the reporting person was issued 12,135 Restricted Stock Units vesting in three equal monthly installments\nbeginning November 1, 2020. The Restricted Stock Units were issued in lieu of quarterly director fees in the amount of $12,500 under\nthe 2019 Equity Incentive Plan."}],"balance_after":68839,"source":{"system":"sec-edgar","filing":"0001493152-20-018912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315220018912/ownership.xml","form_type":"4"}},{"id":3064179,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2020-08-10T21:22:00.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":17000,"price":4.98,"value":84660.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-08-06","expiration_date":"2030-08-06","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000719135-20-000061","document":"wf-form4_159709450745295.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913520000061/wf-form4_159709450745295.xml","form_type":"4"}},{"id":3113407,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T16:16:14.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":6124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":6124,"derivative":{"exercise_price":7.96,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":6124},"source":{"system":"sec-edgar","filing":"0000899243-20-016165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924320016165/doc4.xml","form_type":"4"}},{"id":3184137,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T08:00:20.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":11574,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as restricted share units pursuant to the 2019 Equity Incentive Plan for a quarterly director fee in the amount of\n$12,500, or $1.08 per share, and vest in three equal monthly installments beginning May 1, 2020."}],"balance_after":56704,"source":{"system":"sec-edgar","filing":"0001493152-20-005754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315220005754/ownership.xml","form_type":"4"}},{"id":3319349,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:05:35.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":38269,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as restricted share units pursuant to the 2019 Equity Incentive Plan for annual director fees totaling $99,500 or $2.60 per share. The shares vest in 12 equal monthly installments beginning February 1, 2020."}],"balance_after":45130,"source":{"system":"sec-edgar","filing":"0001493152-20-000216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315220000216/ownership.xml","form_type":"4"}},{"id":3347077,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-12-10T16:30:12.000Z","date":"2019-12-10","kind":"exercise","acquired":false,"shares":2992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On December 10, 2018, the reporting person was granted 8,975 restricted stock units that vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On December 10, 2018, the reporting person was granted 8,975 restricted stock units that vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On December 10, 2018, the reporting person was granted 8,975 restricted stock units that vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."}],"balance_after":5983,"derivative":{"underlying":"Common Stock","underlying_shares":2992},"source":{"system":"sec-edgar","filing":"0001493152-19-018980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315219018980/ownership.xml","form_type":"4"}},{"id":3347076,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-10T16:30:12.000Z","date":"2019-12-10","kind":"exercise","acquired":true,"shares":2992,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On December 10, 2018, the reporting person was granted 8,975 restricted stock units that vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."}],"balance_after":6861,"source":{"system":"sec-edgar","filing":"0001493152-19-018980","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315219018980/ownership.xml","form_type":"4"}},{"id":3399110,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-03T16:15:22.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":3869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as a restricted share award pursuant to the 2019 Equity Incentive Plan in lieu of director fees of $12,500. The shares vest in three equal monthly installments beginning November 1, 2019."}],"balance_after":3869,"source":{"system":"sec-edgar","filing":"0001493152-19-014949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315219014949/ownership.xml","form_type":"4"}},{"id":3482439,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T16:19:14.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":6124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 18, 2020, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":6124,"derivative":{"exercise_price":3.37,"exercise_date":"2020-06-18","expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":6124},"source":{"system":"sec-edgar","filing":"0000899243-19-017643","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924319017643/doc4.xml","form_type":"4"}},{"id":3734488,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-12T11:30:22.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":19329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 3 equal annual installments beginning on December 10, 2019."}],"balance_after":19329,"derivative":{"exercise_price":13.65,"expiration_date":"2028-12-09","underlying":"Common Stock","underlying_shares":19329},"source":{"system":"sec-edgar","filing":"0001493152-18-017370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315218017370/ownership.xml","form_type":"4"}},{"id":3734487,"issuer":{"id":117561,"kind":"organization","name":"POLARITYTE, INC.","symbol":"PTE"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-12-12T11:30:22.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":8975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest at the rate of 2,992 shares on December 10, 2019 and 2020, and 2,991 shares on December 10, 2021."}],"balance_after":8975,"derivative":{"underlying":"Common Stock","underlying_shares":8975},"source":{"system":"sec-edgar","filing":"0001493152-18-017370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076682/000149315218017370/ownership.xml","form_type":"4"}},{"id":3862231,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":38436,"kind":"person","name":"Baylor-Henry Minnie","position":1,"cik":"0001747260","reported_name":"Baylor-Henry Minnie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-24T17:09:53.000Z","date":"2018-07-20","kind":"grant","acquired":true,"shares":12248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of such stock option shall vest on the first anniversary of the grant date, and the remainder shall vest in equal monthly installments over the following two year period."}],"balance_after":12248,"derivative":{"exercise_price":4.8,"expiration_date":"2028-07-20","underlying":"Common Stock","underlying_shares":12248},"source":{"system":"sec-edgar","filing":"0000899243-18-020523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000089924318020523/doc4.xml","form_type":"4"}}]}